
According to the FDA, the operators were procuring lower-cost medicines from other states and allegedly filling them into new vials before relabelling them to resemble expensive multinational and imported drug brands.
According to the FDA, the operators were procuring lower-cost medicines from other states and allegedly filling them into new vials before relabelling them to resemble expensive multinational and imported drug brands.

This article was originally published by an external source. Read the full story at the source.
Read Full Article at Source ↗